menu
    • menu

    Company profile for Advicenne

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Advicenne, we are committed to innovating in the areas of formulation and clinical development. Tasteless and easy to administer, ADV7103 will be commercialized in small-size formats that offer flexible, personalized dosing – because pathbreaking treatments for rare diseases should be available to patients of all ages.Headquartered in Nîmes, France, Advicenne was listed on the Euronext Paris stock exchange in December 20...
    At Advicenne, we are committed to innovating in the areas of formulation and clinical development. Tasteless and easy to administer, ADV7103 will be commercialized in small-size formats that offer flexible, personalized dosing – because pathbreaking treatments for rare diseases should be available to patients of all ages.Headquartered in Nîmes, France, Advicenne was listed on the Euronext Paris stock exchange in December 2017

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdvicenneFrance Flag
    Country
    Country
    France
    Address
    Address
    22 Rue de la Paix – 3ème étage F-75002 Paris
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://advicenne.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/advicenne-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Advicenne Reports Its 2025 Annual Financial Results
    Advicenne Reports Its 2025 Annual Financial Results

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/advicenne-reports-its-2025-annual-financial-results

    PHARMIWEB
    26 Mar 2026
    Share Share
    Advicenne Secures Official Reimbursement For Sibnayal In French
    Advicenne Secures Official Reimbursement For Sibnayal In French

    02 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-02/advicenne-official-reimbursement-of-sibnayal-for-the-treatment-of-drta-in-france

    PHARMIWEB
    02 Feb 2026
    Share Share
    Advicenne: 2025 Full-Year Sales Results
    Advicenne: 2025 Full-Year Sales Results

    22 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-22/advicenne-2025-full-year-sales

    PHARMIWEB
    22 Jan 2026
    Share Share
    Advicenne: 2026 Financial Calendar
    Advicenne: 2026 Financial Calendar

    20 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-20/advicenne-2026-financial-calendar

    PHARMIWEB
    20 Jan 2026
    Share Share
    FDA Accepts Sibnayal MAA For dRTA Treatment In US
    FDA Accepts Sibnayal MAA For dRTA Treatment In US

    19 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-19/advicenne-fda-has-accepted-for-review-the-marketing-authorization-application-for-sibnayal-in-the

    PHARMIWEB
    19 Jan 2026
    Share Share
    FDA Accepts Sibnayal NDA for dRTA Treatment in the US
    FDA Accepts Sibnayal NDA for dRTA Treatment in the US

    19 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-19/advicenne-fda-has-accepted-for-review-the-marketing-authorization-application-for-sibnayal-in-the

    PHARMIWEB
    19 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search